In line with this, BDNF suppression was also observed in animal models after administration of uremic toxins such as indoxyl sulfate (Sun et al., 2021) and p-cresyl sulfate (Sun et al., 2020), indicating that CKD-related metabolic disruptions may impair BDNF synthesis or release. This evidence concerns the gene BDNF and chronic kidney disease.